Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25F6XPF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., covers the supply of EXPAREL 266 mg/20 mL vials with a firm fixed price ceiling of $25,106.30 and an ultimate completion date of August 13, 2025. EXPAREL is a liposomal bupivacaine formulation used for surgical anesthesia and post-operative pain management. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its capabilities as a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, holds a substantial $499.999 billion Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program valid through November 2026. This delivery order represents one discrete pharmaceutical fulfillment under that larger contract vehicle, which enables the agency to procure a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. The company has demonstrated consistent success in federal pharmaceutical procurement, leveraging its established distribution network and SAM.gov registration dating to 2001 to serve military medical supply requirements across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DX25F6XPF?
SPE2DX25F6XPF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 23, 2025.
How much is contract SPE2DX25F6XPF worth?
The government has obligated $25,106 on SPE2DX25F6XPF.
Is contract SPE2DX25F6XPF an order under another contract?
Yes. SPE2DX25F6XPF is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPF competed?
The extent of competition for SPE2DX25F6XPF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award